Despite comparing only three lines derived from PD patients carrying LRRK2-G2019S variants to three controls lines, the differential gene expression pattern identified is both correlated with the effects of PD-inducing compounds and anti-correlated to the effects of compounds found to have efficacy in alleviating PD symptoms in rodent models. The gene discussed is LRRK2; the disease is Parkinson disease.